13q14 Deletion Size and Number of Deleted Cells Both Influence Prognosis in Chronic Lymphocytic Leukemia

被引:64
作者
Dal Bo, Michele [1 ]
Rossi, Francesca Maria [1 ]
Rossi, Davide [2 ,3 ]
Deambrogi, Clara [2 ,3 ]
Bertoni, Francesco [4 ,5 ]
Del Giudice, Ilaria [6 ]
Palumbo, Giuseppe [7 ]
Nanni, Mauro [6 ]
Rinaldi, Andrea [4 ,5 ]
Kwee, Ivo [4 ,5 ,8 ]
Tissino, Erika [1 ]
Corradini, Giorgia [9 ]
Gozzetti, Alessandro [10 ]
Cencini, Emanuele [10 ]
Ladetto, Marco [11 ]
Coletta, Angela Maria [12 ,13 ]
Luciano, Fabrizio [12 ,13 ]
Bulian, Pietro [1 ]
Pozzato, Gabriele [14 ]
Laurenti, Luca [15 ]
Forconi, Francesco [10 ]
Di Raimondo, Francesco [7 ]
Marasca, Roberto [9 ]
Del Poeta, Giovanni [12 ,13 ]
Gaidano, Gianluca [2 ,3 ]
Foa, Robin [6 ]
Guarini, Anna [6 ]
Gattei, Valter [1 ]
机构
[1] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy
[2] Amedeo Avogadro Univ Eastern Piedmont, Dept Clin & Expt Med, Div Hematol, Novara, Italy
[3] Amedeo Avogadro Univ Eastern Piedmont, IRCAD, Novara, Italy
[4] Oncol Inst So Switzerland IOSI, Expt Oncol Lab, Bellinzona, Switzerland
[5] Oncol Inst So Switzerland IOSI, Lymphoma Unit, Bellinzona, Switzerland
[6] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy
[7] Ferrarotto Hosp, Div Hematol, Catania, Italy
[8] Ist Dalle Molle Studi Intelligenza Artificiale ID, Manno, Switzerland
[9] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Div Hematol, Modena, Italy
[10] Univ Siena, Div Hematol & Transplant, Dept Clin Med & Immunol Sci, I-53100 Siena, Italy
[11] Univ Turin, Dept Expt Med & Oncol, Div Hematol, I-10124 Turin, Italy
[12] S Eugenio Hosp, Div Hematol, Rome, Italy
[13] Univ Roma Tor Vergata, Rome, Italy
[14] Univ Trieste, Maggiore Gen Hosp, Dept Internal Med & Hematol, Trieste, Italy
[15] Univ Cattolica Sacro Cuore, Inst Hematol, Rome, Italy
关键词
TUMOR-SUPPRESSOR GENE; MUTATION STATUS; GENOMIC ABERRATIONS; PROTEIN EXPRESSION; ZAP-70; EXPRESSION; CYCLE PROGRESSION; CHROMOSOME; 13Q14; CD38; DOWN-REGULATION; REGION;
D O I
10.1002/gcc.20885
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Deletion at 13q14 is detected by fluorescence in situ hybridization (FISH) in about 50% of chronic lymphocytic leukemia (CLL). Although CLL with 13q deletion as the sole cytogenetic abnormality (del13q-only) usually have good prognosis, more aggressive clinical courses are documented for del13q-only CLL carrying higher percentages of 13q deleted nuclei. Moreover, deletion at 13q of different sizes have been described, whose prognostic significance is still unknown. In a multi-institutional cohort of 342 del13q-only cases and in a consecutive unselected cohort of 265 CLL, we investigated the prognostic significance of 13q deletion, using the 13q FISH probes locus-specific identifier (LSI)-D13S319 and LSI-RB1 that detect the DLEU2/MIR15A/MIR16-1 and RB1 loci, respectively. Results indicated that both percentage of deleted nuclei and presence of larger deletions involving the RB1 locus cooperated to refine the prognosis of del13q-only cases. In particular, CLL carrying < 70% of 13q deleted nuclei with deletions not comprising the RB1 locus were characterized by particularly long time-to-treatment. Conversely, CLL with 13q deletion in < 70% of nuclei but involving the RB1 locus, or CLL carrying 13q deletion in >= 70% of nuclei, with or without RB1 deletions, collectively experienced shorter time-to-treatment. A revised flowchart for the prognostic FISH assessment of del13q-only CLL, implying the usage of both 13q probes, is proposed. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:633 / 643
页数:11
相关论文
共 31 条
  • [31] Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia
    Miao, Yi
    Wang, Rong
    Fan, Lei
    Qiu, Hairong
    Wu, Yujie
    Chen, Yaoyu
    Xu, Wei
    Li, Jianyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 7494 - 7498